Top Section/Ad
Top Section/Ad
Most recent
Galderma will provide the European IPO market with another important data point when it begins trading on Friday
The final size of the base deal will be Sfr2bn after the IPO was priced at the top of the range
The biggest IPO of the year so far in Europe is multiple times covered, according to sources
KBRA expects to upgrade deal if merger with Orangetheory goes through
More articles/Ad
More articles/Ad
More articles
-
US drug maker's stake in Haleon set to fall to 24%
-
Risk appetite is back and more deals coming, though one bad IPO would damage confidence in the recovery
-
More companies are getting ratings to woo bond investors
-
Europe's biggest IPO of the year so far gains traction with investors
-
After the listings in February delivered, Galderma adds fuel to the European IPO recovery
-
Long delayed listing of Nestlé's former skincare division is finally underway